We did not identify any association between the variant 5'UTR alleles and MS, suggesting that these insertion/deletion (in/del) variants in the Sp1/Egr-1 binding sites are not pathogenic in MS, and may not be the cause of the increased ALOX5 expression measured in MS patients by microarray analysis. The gene discussed is ALOX5; the disease is myeloid sarcoma.